From Clinic to Courtroom – Legislation and Litigation Limiting Prescription Drug Practices
10:00 a.m. – 11:10 a.m. (ET)
Considerable efforts have been made in recent years to reduce the runaway health care costs that workers and employers increasingly face. Perhaps the most contentious area of this developing health care fight surrounds prescription drug practices, which have seen broad expansion in recent years but are now under renewed fire from opponents. State legislators and regulators are considering everything from telehealth prescribing standards, to specialty “white/brown bagging” services, to abortion medication access, and regulation of pharmacy benefit managers. Join our panel discussion to learn more about the prescription drug policies that are emerging on the state level, the legal standards at issue in related litigation, and what is at stake for employer-sponsored health plans at large.
Meet the Panelists
Director, State Advocacy and Litigation
The ERISA Industry Committee
Counsel
McDermott Will & Emery
Head of Policy & Government Affairs Included Health
Shareholder
Chambliss, Bahner & Stophel, P.C.